INSM
Insmed Incorporated
NASDAQ · Healthcare · Biotechnology · US
$126.29
−0.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 131.68x
- P/E 2028E
- 34.80x
- P/S forward
- 11.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 36.41x
- Price / sales
- 24.24x
- Price / cash flow
- -35.41x
Enterprise value
- Enterprise value
- $27.0B
- EV / sales
- 23.73x
- EV / EBITDA
- -35.06x
- EV / EBIT
- -33.02x
- Market cap
- $27.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026